Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6.
Google ScholarÂ
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.
Google ScholarÂ
Rumgay H, Ferlay J, de Martel C, Georges D, Ibrahim AS, Zheng R, et al. Global, regional and national burden of primary liver cancer by subtype. Eur J Cancer. 2022;161:108–18.
Google ScholarÂ
Tsuchida T, Lee YA, Fujiwara N, Ybanez M, Allen B, Martins S, et al. A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. J Hepatol. 2018;69:385–95.
Google ScholarÂ
Jiang Y, Sun A, Zhao Y, Ying W, Sun H, Yang X, et al. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma. Nature. 2019;567:257–61.
Google ScholarÂ
Hu N, Fu Y, Li WF, Yang XR, Cao M, Li FF, et al. Chemical mitochondrial uncouplers share a common inhibitory effect on NLRP3 inflammasome activation through inhibiting NFκB nuclear translocation. Toxicol Appl Pharmacol. 2021;414:115426.
Google ScholarÂ
Pauels L, De Waele M, Medart L, Debruche M. Two unusual variants of pulmonary intra-lobar sequestration. Interact Cardiovasc Thorac Surg. 2022;35:ivac189.
Che L, Chi W, Qiao Y, Zhang J, Song X, Liu Y, et al. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans. Gut. 2020;69:177–86.
Google ScholarÂ
Mamais A, Wallings R, Rocha EM. Disease mechanisms as subtypes: Lysosomal dysfunction in the endolysosomal Parkinson’s disease subtype. Handb Clin Neurol. 2023;193:33–51.
Google ScholarÂ
Gong X, Qian H, Zhou X, Wu J, Wan T, Cao P, et al. Structural insights into the Niemann-Pick C1 (NPC1)-mediated cholesterol transfer and Ebola infection. Cell. 2016;165:1467–78.
Google ScholarÂ
Xu J, Chen F, Zhu W, Zhang W. NPC1 promotes autophagy with tumor promotion and acts as a prognostic model for hepatocellular carcinoma. Gene. 2024;897:148050.
Google ScholarÂ
Li S, Yan L, Li C, Lou L, Cui F, Yang X, et al. NPC1 controls TGFBR1 stability in a cholesterol transport-independent manner and promotes hepatocellular carcinoma progression. Nat Commun. 2025;16:439.
Google ScholarÂ
Pfeffer SR. NPC intracellular cholesterol transporter 1 (NPC1)-mediated cholesterol export from lysosomes. J Biol Chem. 2019;294:1706–9.
Google ScholarÂ
Ahmad I, Fatemi SN, Ghaheri M, Rezvani A, Khezri DA, Natami M, et al. An overview of the role of Niemann-Pick C1 (NPC1) in viral infections and the inhibition of viral infections through NPC1 inhibitor. Cell Commun Signal. 2023;21:352.
Google ScholarÂ
Davis OB, Shin HR, Lim CY, Wu EY, Kukurugya M, Maher CF, et al. NPC1-mTORC1 signaling couples cholesterol sensing to organelle homeostasis and is a targetable pathway in Niemann-Pick type C. Dev Cell. 2021;56:260–276.e267.
Google ScholarÂ
Hussain SP, Schwank J, Staib F, Wang XW, Harris CC. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene. 2007;26:2166–76.
Google ScholarÂ
Meng X, Franklin DA, Dong J, Zhang Y. MDM2-p53 pathway in hepatocellular carcinoma. Cancer Res. 2014;74:7161–7.
Google ScholarÂ
Liu Y, Su Z, Tavana O, Gu W. Understanding the complexity of p53 in a new era of tumor suppression. Cancer Cell. 2024;42:946–67.
Google ScholarÂ
Huang Y, Che X, Wang PW, Qu X. p53/MDM2 signaling pathway in aging, senescence and tumorigenesis. Semin Cancer Biol. 2024;101:44–57.
Google ScholarÂ
Marine JC, Lozano G. Mdm2-mediated ubiquitylation: p53 and beyond. Cell Death Differ. 2010;17:93–102.
Google ScholarÂ
Li M, Brooks CL, Kon N, Gu W. A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol Cell. 2004;13:879–86.
Google ScholarÂ
Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J, et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature. 2002;416:648–53.
Google ScholarÂ
Fang D, Hu H, Zhao K, Xu A, Yu C, Zhu Y, et al. MLF2 negatively regulates p53 and promotes colorectal carcinogenesis. Adv Sci. 2023;10:e2303336.
Google ScholarÂ
Moon SH, Huang CH, Houlihan SL, Regunath K, Freed-Pastor WA, Morris JPT, et al. p53 represses the mevalonate pathway to mediate tumor suppression. Cell. 2019;176:564–580.e519.
Google ScholarÂ
Fu L, Deng R, Huang Y, Yang X, Jiang N, Zhou J, et al. DGKA interacts with SRC/FAK to promote the metastasis of non-small cell lung cancer. Cancer Lett. 2022;532:215585.
Google ScholarÂ
Sankar K, Gong J, Osipov A, Miles SA, Kosari K, Nissen NN, et al. Recent advances in the management of hepatocellular carcinoma. Clin Mol Hepatol. 2024;30:1–15.
Google ScholarÂ
Brown ZJ, Tsilimigras DI, Ruff SM, Mohseni A, Kamel IR, Cloyd JM, et al. Management of hepatocellular carcinoma: a review. JAMA Surg. 2023;158:410–20.
Google ScholarÂ
Yang X, Yang C, Zhang S, Geng H, Zhu AX, Bernards R, et al. Precision treatment in advanced hepatocellular carcinoma. Cancer Cell. 2024;42:180–97.
Google ScholarÂ
Hu J, Cao J, Topatana W, Juengpanich S, Li S, Zhang B, et al. Targeting mutant p53 for cancer therapy: direct and indirect strategies. J Hematol Oncol. 2021;14:157.
Google ScholarÂ
Tavana O, Gu W. Modulation of the p53/MDM2 interplay by HAUSP inhibitors. J Mol Cell Biol. 2017;9:45–52.
Google ScholarÂ
Cummins JM, Rago C, Kohli M, Kinzler KW, Lengauer C, Vogelstein B. Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature. 2004;428:1 p following 486.
Cummins JM, Vogelstein B. HAUSP is required for p53 destabilization. Cell Cycle. 2004;3:689–92.
Google ScholarÂ
Li X, Wang J, Coutavas E, Shi H, Hao Q, Blobel G. Structure of human Niemann-Pick C1 protein. Proc Natl Acad Sci USA. 2016;113:8212–7.
Google ScholarÂ
O’Neill KI, Kuo LW, Williams MM, Lind H, Crump LS, Hammond NG, et al. NPC1 confers metabolic flexibility in triple-negative breast cancer. Cancers. 2022;14:3543.
Fazliyeva R, Makhov P, Uzzo RG, Kolenko VM. Targeting NPC1 in renal cell carcinoma. Cancers. 2024; 16:517.
Millard EE, Srivastava K, Traub LM, Schaffer JE, Ory DS. Niemann-Pick type C1 (NPC1) overexpression alters cellular cholesterol homeostasis. J Biol Chem. 2000;275:38445–51.
Google ScholarÂ
Schwend T, Loucks EJ, Snyder D, Ahlgren SC. Requirement of Npc1 and availability of cholesterol for early embryonic cell movements in zebrafish. J Lipid Res. 2011;52:1328–44.
Google ScholarÂ
